Investors' Chronicle

Julian Hofmann, a seasoned pharmaceuticals expert, shares insights on AstraZeneca's potential blockbuster breast cancer drug, Enhertu, and the company’s strategic shifts. Val Cipriani, a business journalist, discusses the 'Great Wealth Transfer' and offers advice on gifting and inheritance tax, emphasizing planning for family wealth. Finally, Mark Robinson analyzes Ceres Power's disappointing interim results, Bosch’s exit, and the company's pivot toward growing tech markets, specifically data centers. Tune in for valuable insights!

We begin with Trustpilot’s (TRST) results. Mark Robinson and Dan delve into what has gone right and wrong for the company, its durability in an age of AI, and our take on its use of buybacks.Alex Hamer then covers the North Sea Energy Profits Levy. From the effect current policies are having on production to the companies that see opportunity in the region, Alex covers all that investors need to know.Last up, Goodwin (GDWN), the 140-year-old Stoke-based engineering and manufacturing company. Alex Newman touches on the history of the business, its most recent trading update and if its years of investment are finally paying off.Timestamps 1:31 Trustpilot13:34 North Sea27:21 GoodwinRead the stories mentioned in the show: Trustpilot grows revenue as AI boosts its subscription modelNorth Sea oil stocks bet on government U-turnGoodwin: A 143-year-old firm flying under the radarMeeting M&G’s CEO: Lee and the IC Hosted on Acast. See acast.com/privacy for more information.

Reuniting after the summer, Lord Lee and Alex Newman sit down in the M&G offices with Andrea Rossi, CEO since 2022. In the episode, the trio unpack what drew Rossi to take on the role, the challenges of balancing £350bn of assets, and how the affiliate deal with the Japanese life insurer Dai Ichi could transform the company, and more. Alex and Lord Lee wrap up in usual fashion with an update on Lord Lee’s portfolio, including a relatively unknown family-run Plc that’s crucial to the UK’s submarine programme.If you have any questions or any suggestions for future guests, email alex.newman@ft.comTimestamps 1:09 Rossi’s impression of the business prior to joining2:18 Why Rossi did not want to break up the group4:13 What Rossi sees in private markets 7:58 The challenge of valuing a business such as M&G14:36 Would private ownership be a better fit?16:02 The Dai Ichi deal17:43 Managing £350bn of assets20:38 Replicating deals elsewhere in the world21:22 Working in the Gulf23:17 How Rossi allocates capital26:12 Will M&G move into the ETF world 27:32 How optimistic is Rossi on M&G29:31 Lord Lee’s portfolio Hosted on Acast. See acast.com/privacy for more information.

We start with last week’s Big Read, our annual Top 50 Funds. Dave Baxter shares his thoughts on compiling the list, its structure and the changes made to this year's edition. GSK (GSK), a company featured in our latest Special Report this week, Income Majors, is next. Its dividend level is not as high as it has been, but it is expected to tick up. Julian Hofmann unpacks its valuation, the possible buybacks on the table, what it's doing to boost sales and more.Last up, it’s Mondi (MNDI), the packaging and paper company, which has had a tough year. Valeria Martinez covers the reasons, what it's doing during the slump it's experiencing and when investors can expect a recovery.Timestamps 1:30 Top 50 Funds14:13 GSK26:17 MondiRead stories mentioned in the show:IC Top 50 Funds: the best ones to buyIncome Majors 2025: How the UK’s biggest dividend payers are faring Hosted on Acast. See acast.com/privacy for more information.

We begin with the £42bn mega-merger between Anglo American and Teck Resources. Commodities expert Alex Hamer lays out what the deal is, the strengths Anglo will gain from it, and its investment case moving forward. It’s then on to Aim-traded Property Franchise Group with Mark Robinson. The recent results show momentum is strong, with many of its divisions performing well. Mark and Dan take a look at its valuation case against the market backdrop. DIY chain Wickes has demonstrated resilience in the face of a relatively flat home improvement market. Erin Withey shares where the company is taking market share and why the market didn’t react much to its interim results. Timestamps1:16 Anglo American - Tech Resources Merger17:45 Property Franchise Group29:34 Wickes Hosted on Acast. See acast.com/privacy for more information.

We start with this week’s Big Read by Chris Akers on Europe’s stand-out stocks, which have been beating their US counterparts. Chris lays out the background for the piece, the positives and the negatives on the continent, and highlights the sectors and countries investors may be particularly interested in.Next up, investment clubs. Many of our listeners will be well-versed on the topic, but for those who are not, Holly McKechnie lays out what they are, the number of clubs in the UK at the last count and their future in light of Interactive Investors’ announcement.Last up, Mark Robinson talks through Uniphar’s (UPR) latest results. The Irish Aim-traded pharmaceutical company’s share price has doubled in the past year, so Mark and Dan unpack what went right and how tariffs may affect the business. Timestamps1:22 European markets15:21 Investment clubs23:34 Uniphar Hosted on Acast. See acast.com/privacy for more information.

We start with commodities expert Alex Hamer, the author of this week’s Big Read on nuclear power. Tech giants' need for the contentious energy source has revived plants around the globe. Alex unpacks what this means for the industry so far, and the prospects for the uranium market and small modular reactors (SMRs). Next up, the world’s most valuable company, Nvidia (NVDA). New York-based reporter Arthur Sants discusses the company’s latest results, the uncertainty regarding sales to China, as well as Intel’s two recent big investors: the US government and SoftBank. Alex Newman also weighs in on the subject. Mark Robinson covers Boohoo’s (DEBS) recent, delayed results, which showed some overhang from its old business. It’s move to be a third-party seller, similar to that of M&S (MKS) and Next (NXT) could be fruitful, but the competition is rife. Listen to find out more. Timestamps1:30 Nuclear 15:48 Nvidia 37:07 BoohooRead more on these topics How to invest in the world’s nuclear futureNvidia beats expectations despite China uncertaintyBoohoo cuts inventories and capex Hosted on Acast. See acast.com/privacy for more information.

We begin with Mark Robinson talking PensionBee’s (PBEE) results. The company’s marketing push in the US was a key theme in its latest update, a region where it sees a big opportunity. Mark and Dan discuss how both its US and UK arms are faring, as well as its valuation case.Next up, Holly McKechnie discusses our latest Big Read on beating the trap of leasehold properties. Holly and Dan unpack everything from how to spot issues when renting or buying a leasehold to the impact Labour’s reforms will have.Last up, Valeria Martinez covers whey-based protein products producer Applied Nutrition (APN). Its second-half results showed good performance thanks to well-received product launches. Valeria explains why momentum is on the company’s side.Timestamps 1:25 PensionBee18:00 Leaseholds34:48 Applied Nutrition  Hosted on Acast. See acast.com/privacy for more information.

We begin with Hugh Moorhead and recent results from Savills (SVS), which were in line with expectations. Hugh and Dan unpack what divisions brought in the highest profits, a breakdown of a handful of global performances, and what the business’s valuation appears to be.Next up James Norrington joins to unpack our latest Big Read on sum-of-the-parts valuations. James explains the thinking behind the piece, how it can help find stocks trading at less than their worth, and how to tell if a company is focusing on the right part of a business.Lastly, Julian Hofmann covers Novo Nordisk (DK:NOVO.B), which saw shares rise after Eli Lilly’s (US:LLY) oral weight-loss pill underwhelmed regulators. Competition is still fierce in the sector, but a new Novo CEO could give the company the boost it needs. Read more on these topics How to spot undervalued sharesDeep DivesTimestamps 1:16 Savills13:41 Spotting undervalued shares26:33 Weight loss drugs Hosted on Acast. See acast.com/privacy for more information.

Valeria Martinez, a savvy analyst of company results and market trends, dives into the latest figures from asset manager Jupiter, questioning its recovery trajectory. She also explores the intricacies of retirement planning, explaining how to identify your retirement profile and manage assets for financial security. Lastly, Valeria discusses the impressive cash position of Science Group following its activist campaign against rival Ricardo, outlining the company's strategic shifts and growth potential amid market challenges.